Options Brief: Salix Pharmaceuticals (SLXP)

Shares of Salix Pharmaceuticals SLXP are higher on the session by 1.95%, trading at $41.77. Overall put volume is now running at 2.68x the daily average, with 67% of all puts traded being purchases on the offer. 1,353 contracts have traded on the session so far. Salix Pharmaceuticals, Ltd. is a specialty pharmaceutical company dedicated to acquiring, developing and commercializing prescription drugs used in the treatment of a variety of gastrointestinal diseases, which are affecting the digestive tract.